Puma Biotechnology Inc - Common Stock (NQ:PBYI)

10.03 +0.10 (+1.01%)

Delayed Quote Updated: 2:27 PM EDT, Oct 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Puma Biotechnology Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

March 03, 2023

From Puma Biotechnology, Inc.

Via Business Wire

Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 03, 2023

Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

Via Benzinga

Why Shares of Puma Biotechnology Rose This Week ↗

December 15, 2022

The company's CEO bought $2.5 million worth of company stock.

Via The Motley Fool

Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results

March 02, 2023

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology to Participate in a Panel Discussion at Cowen’s 43rd Annual Health Care Conference

February 28, 2023

From Puma Biotechnology, Inc.

Via Business Wire

7 A-Rated Penny Stocks Worth Betting On ↗

February 19, 2023

Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance.

Via InvestorPlace

Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results

February 16, 2023

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

February 07, 2023

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Breast Cancer with a HER2 Mutation

February 01, 2023

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology to Present at B. Riley Securities’ 3rd Annual Oncology Conference

January 12, 2023

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

January 11, 2023

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Releases Updated Corporate Presentation

January 09, 2023

From Puma Biotechnology, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 26, 2022

Via Benzinga

Puma Biotechnology Presents Updated Findings from the TBCRC-022 Trial at the 2022 San Antonio Breast Cancer Symposium

December 07, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

December 05, 2022

From Puma Biotechnology, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 25, 2022

Via Benzinga

Why Puma Biotechnology's Shares Jumped 20% on Monday ↗

November 21, 2022

It may have benefited from positive news about another company's drug candidate.

Via The Motley Fool

Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday ↗

November 28, 2022

Gainers AEye, Inc. (NASDAQ: LIDR) shares jumped 50% to close at $1.25 on Friday. AEye recently posted a Q3 loss of $0.11 per share.

Via Benzinga

Takeda's Approved Blood Cancer Drug Hits Primary Goal In Newly-Diagnosed Patient Settings ↗

November 17, 2022

Via Benzinga

S&P 500 Down 1%; Crude Oil Drops Sharply ↗

November 17, 2022

U.S. stocks traded lower midway through trading, with the S&P 500 dropping around 1% on Thursday.

Via Benzinga

Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday ↗

November 22, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

Short Volatility Alert: Puma Biotechnology, Inc. ↗

November 09, 2022

On Tuesday, shares of Puma Biotechnology, Inc. (NASDAQ: PBYI) experienced volatile short activity. After the activity, the stock price went up +3.99% to $3.26. The overall sentiment for PBYI has been...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

November 21, 2022

During Monday's session, 50 stocks hit new 52-week highs.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 04, 2022

Gainers

Via Benzinga

Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday ↗

November 07, 2022

Gainers

Via Benzinga

Puma Biotechnology Reports Third Quarter 2022 Financial Results

November 03, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

November 02, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology's Earnings Outlook ↗

November 02, 2022

Puma Biotechnology (NASDAQ:PBYI) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Puma...

Via Benzinga

Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib in EGFR Exon 18-Mutant NSCLC at the 2022 EORTC/NCI/AACR Symposium

October 27, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results

October 20, 2022

From Puma Biotechnology, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.